三级aa视频在线观看-三级国产-三级国产精品一区二区-三级国产三级在线-三级国产在线

Global EditionASIA 中文雙語Fran?ais
Opinion
Home / Opinion / Opinion Line

No tariffs on targeted cancer drugs will reduce the price pain for patients

China Daily | Updated: 2018-03-22 07:07
Share
Share - WeChat

Premier Li Keqiang promises zero tariff rates for targeted cancer drugs at a news conference after the two sessions in Beijing on Tuesday. Thepaper.cn comments:

It is estimated more than 2 million people die of cancer in China each year. If there are zero tariffs, the retail price of the imported lifesaving drugs used in targeted cancer therapies will drop markedly. Their high prices have resulted in a large number of cancer patients exhausting their savings to extend their lives for a short time.

Some imported targeted cancer therapies can cost a patient as much as 10,000 yuan ($1,579) a dose as they are not covered by the medical insurance system. The high prices mean many patients have to give up their treatment.

More and more patients have turned to buying medicines from India through various channels as the prices are much lower, or to generic drugs that are lower in both price and efficiency. They then take the medicines at home without professional instruction and monitoring, further risking their health.

Aside from the tariffs, the high retail price of imported drugs in China is also pushed up by agents' fees, value-added tax, and high basic prices, which stem from the super-national treatment that some foreign medicines have been enjoying in the drug procurement of public hospitals, even if some of their patent protections have expired.

The pledge to end the tariffs on targeted cancer therapies indicates that the government recognizes they are special goods concerning people's welfare. But even without the tariffs, there still remains considerable room to squeeze the profit links between customs and patients to further bring down the prices of the drugs.

That the government has to open doors to imported drugs to save people's lives should also ring alarm bells for domestic pharmaceutical companies, especially the State-owned ones, as they have no reasons to sit idle, and are obliged to strengthen their research into these badly needed medicines and try their best to acquire the ability of producing them as early as possible.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 在线观看视频日韩 | 免费一级特黄3大片视频 | 免费日本黄色 | 日韩毛片在线视频 | 国产大伊香蕉精品视频 | 青青久在线精品视频 | 91视频免费网址 | 亚洲午夜久久久精品影院视色 | 精品在线免费视频 | 国产精品线在线精品国语 | 成人午夜久久精品 | 国产免费做爰午夜视频 | 欧美三级一区 | 一级特级aa欧美毛片 | 成人免费视频在线播放 | 大香萑75久久精品免费 | 日韩在线视屏 | 欧美一欧美一区二三区性 | 孕交欧美videos | 久久精品免费一区二区三区 | 国产成人在线播放 | 鲁丝一区二区三区不属 | 九九热精品免费视频 | 97精品国产自在现线免费观看 | 亚洲国产情侣偷自在线二页 | 女女互添下身免费视频 | 唐人社区精品视频 | 手机看片福利日韩欧美看片 | 久久久久免费精品国产 | 天天拍拍天天爽免费视频 | 黄色a视频在线观看 | 91久久福利国产成人精品 | 黄色大片一级片 | 天堂福利视频在线观看 | 国产短视频精品一区二区三区 | 国产精品色婷婷在线观看 | 91sex在线观看免费 | 欧美a级v片在线观看一区 | 91麻豆国产在线观看 | 久久久综合网 | 成人免费一级在线播放 |